TENAX THERAPEUTICS, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
TENAX THERAPEUTICS, INC. (TENX) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of -$150.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2023-03-31
- 2022-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net -$150.00K.
- 2022-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net -$150.00K.
- 2022-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net -$150.00K.
- 2022-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net -$150.00K.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net |
|---|---|
| 2022-12-31 | -$150.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | -$150.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$150.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$150.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$150.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $150.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$21.73M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$150.00K 10-Q · filed 2021-05-17 |
| 2014-04-30 | $12.78M 10-K · filed 2014-07-29 |
| 2014-01-31 | $20.74M 10-Q · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |